-
Signature
-
Susan Grady, Attorney-in-Fact
-
Issuer symbol
-
OTIS
-
Transactions as of
-
03 Feb 2026
-
Net transactions value
-
-$11,090,025
-
Form type
-
4
-
Filing time
-
05 Feb 2026, 19:49:59 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Marks Judith Fran |
Chair, CEO and President, Director |
1 CARRIER PLACE, FARMINGTON |
Susan Grady, Attorney-in-Fact |
05 Feb 2026 |
0001665490 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
OTIS |
Common Stock |
Award |
|
+58,169 |
+26% |
|
279,781 |
03 Feb 2026 |
Direct |
F5 |
| transaction |
OTIS |
Common Stock |
Tax liability |
$1,052,283 |
-12,073 |
-4.3% |
$87.16 |
267,708 |
03 Feb 2026 |
Direct |
|
| transaction |
OTIS |
Common Stock |
Options Exercise |
|
+18,425 |
+6.9% |
|
286,133 |
04 Feb 2026 |
Direct |
F1 |
| transaction |
OTIS |
Common Stock |
Tax liability |
$748,354 |
-8,281 |
-2.9% |
$90.37 |
277,852 |
04 Feb 2026 |
Direct |
|
| transaction |
OTIS |
Common Stock |
Sale |
$4,190,057 |
-46,780 |
-17% |
$89.57 |
231,072 |
04 Feb 2026 |
Direct |
F6 |
| transaction |
OTIS |
Common Stock |
Options Exercise |
$12,259,792 |
+191,799 |
+83% |
$63.92 |
422,871 |
04 Feb 2026 |
Direct |
F4 |
| transaction |
OTIS |
Common Stock |
Disposed to Issuer |
$12,259,772 |
-135,692 |
-32% |
$90.35 |
287,179 |
04 Feb 2026 |
Direct |
|
| transaction |
OTIS |
Common Stock |
Sale |
$5,099,352 |
-56,107 |
-20% |
$90.89 |
231,072 |
05 Feb 2026 |
Direct |
F7, F8 |
| holding |
OTIS |
Common Stock |
|
|
|
|
|
23,000 |
03 Feb 2026 |
by 2025 GRAT |
F9 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
OTIS |
Restricted Stock Units |
Award |
$0 |
+59,305 |
|
$0.000000 |
59,305 |
03 Feb 2026 |
Common Stock |
59,305 |
|
Direct |
F1, F2 |
| transaction |
OTIS |
Restricted Stock Units |
Options Exercise |
$0 |
-18,425 |
-33% |
$0.000000 |
36,862 |
04 Feb 2026 |
Common Stock |
18,425 |
|
Direct |
F1, F3 |
| transaction |
OTIS |
Stock Appreciation Rights |
Options Exercise |
$0 |
-191,799 |
-100% |
$0.000000 |
0 |
04 Feb 2026 |
Common Stock |
191,799 |
$63.92 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney. This form includes transactions effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2025. The plan will terminate on March 1, 2026.